Tag Archives: A

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A) and Protagonist Therapeutics (NASDAQ: PTGX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A – Research Report) and Protagonist Therapeutics (PTGX – Research Report) with bullish sentiments. Agilent (A) In a report released today,

Barclays Sticks to Their Hold Rating for Agilent (A)

Barclays analyst Jack Meehan maintained a Hold rating on Agilent (A – Research Report) today and set a price target of $76.00. The company’s shares closed last Monday at $72.87. According to TipRanks.com, Meehan is a 4-star analyst with an

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Global Blood Therapeutics (NASDAQ: GBT) and La Jolla Pharma (NASDAQ: LJPC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agilent (A – Research Report), Global Blood Therapeutics (GBT – Research Report) and La Jolla Pharma (LJPC – Research Report). Agilent (A) Needham analyst Stephen

A Director at Agilent (NYSE: A) is Selling Shares

Yesterday, a Director at Agilent (A – Research Report), Heidi Fields, sold shares of A for $283.8K. Following Heidi Fields’ last A Sell transaction on September 13, 2018, the stock climbed by 2.1%. See today’s analyst top recommended stocks >>

Agilent (A) Received its Third Buy in a Row

After Deutsche Bank and Robert W. Baird gave Agilent (NYSE: A) a Buy rating last month, the company received another Buy, this time from Jefferies. Analyst Brandon Couillard reiterated a Buy rating on Agilent yesterday and set a price target

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A) and Bausch Health Companies Inc (NYSE: BHC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A – Research Report) and Bausch Health Companies Inc (BHC – Research Report) with bullish sentiments. Agilent (A) In a report